Microinflammation Is the Problem Most Skin Quality Protocols Never Address. Here's Why That Matters — and How INFUSION SQ™ Was Built to Solve It.
Dr. Juan Camilo Calderon
Medical Doctor
Monday,
Our Solution:
Table of content: What you will learn
Listen on the Go
Listen Time 6 mins
Why Most Skin Quality Protocols Plateau
You've treated hyperpigmentation. You've delivered correction protocols. And yet the results plateau — or the condition recurs — faster than the clinical evidence would suggest they should.
The reason is rarely the active ingredient. It's the environment the active ingredient is working in.
Beneath the visible signs of hyperpigmentation and aging, there is almost always a multifactorial microinflammatory component — a self-perpetuating cycle of barrier dysfunction, chronic low-grade inflammation, cellular senescence, extracellular matrix alterations, and dysregulated melanogenesis that compromises the skin's natural regenerative processes.
Treat only the surface. The cycle continues.
The Microinflammatory Cycle — What It Is and Why It Persists
UV exposure doesn't just activate melanocytes. It simultaneously triggers inflammatory cascades, reactive oxygen species generation, and vascular activation. Those signals amplify melanocyte activity, degrade the dermal extracellular matrix, and impair cellular communication — creating a microenvironment where correction is fighting an uphill battle.
This is why:
- → Depigmentation protocols deliver results in-office that fade faster than expected at home.
- → Patients with melasma see improvement during treatment and recurrence shortly after.
- → Skin quality improvements in tone, texture, and firmness don't sustain between sessions.
The microinflammatory environment was never addressed. The protocol treated the outcome, not the mechanism.
How INFUSION SQ™ Was Designed to Address the Environment
INFUSION SQ™ is built around a Biotech Regenerative Complex that targets the microinflammatory environment directly — modulating the triggers and perpetuating factors while simultaneously supporting the physiological regenerative processes that allow healthy skin to express its full quality potential.
PDRN — The Regenerative Constant
Salmon-derived PDRN (Sodium DNA) activates the adenosine A2A receptor — a pathway with well-documented anti-inflammatory and pro-regenerative effects. It stimulates fibroblast activity, supports angiogenesis, and drives tissue repair. It is present in every INFUSION SQ™ formulation as the biological anchor of the system.
Plant-Derived Exosomes — Cellular Communication Restored
Restoring intercellular communication is critical to breaking chronic signaling loops. Purified plant exosomes deliver targeted bio-signals directly into cells, enhancing tissue repair and reinforcing structural skin integrity.
Multi-Pathway Intervention — Why a Single Active Is Never Enough
Hyperpigmentation and aging are not driven by a single mechanism. They are driven by interconnected pathways — oxidative stress, melanogenesis dysregulation, vascular signaling, ECM degradation, and impaired cellular communication — operating simultaneously.
INFUSION SQ BRIGHT, for example, does not simply inhibit tyrosinase. It:
- → Modulates melanogenesis at multiple points simultaneously (Arbutin, Tetrapeptide-30, Niacinamide, Acetyl Hexapeptide-1)
- → Interrupts pigment-forming pathways at the vascular-inflammatory level (Tranexamic Acid)
- → Reduces the oxidative stress that sustains uneven tone (Glutathione, Ascorbyl Glucoside)
- → Supports regenerative tissue recovery via PDRN and the full bioactive peptide complex
This is what multi-pathway intervention means in clinical practice — not more ingredients, but the right ingredients targeting the right mechanisms in the right sequence.
Precision Delivery — Placing Actives Where They Work
The biological effect of any active ingredient depends entirely on where it reaches. INFUSION SQ™ formulations are engineered for precision delivery at the epidermal-dermal interface and superficial-to-mid dermis — the compartment where fibroblast activity, ECM remodeling, and regenerative signaling concentrate.
Microneedling combined with targeted formulations is not additive — it is synergistic. Controlled micro-injuries create delivery channels while simultaneously activating wound-healing pathways. Bioavailability rises. Regenerative signaling is amplified. The clinical result is a system where delivery and activation work together, not in sequence.
Evidence: microneedling combined with Vitamin C reduced MASI scores from 8.61 to 5.75 across six sessions (p<0.0001). Microneedling with Glutathione showed 55.17% improvement versus 46.92% with microneedling alone.
The Clinical Implication for Your Practice
Addressing the microinflammatory environment is not a departure from the protocols you already use. It is the foundation that makes those protocols work more effectively, sustain results longer, and create the conditions for genuine skin quality improvement — not just surface correction.
INFUSION SQ™ was built to be that foundation. A system that modulates the environment while activating regenerative pathways — so that the results you deliver in-office hold between sessions, and the skin quality you build progresses over time.
Explore the INFUSION SQ™ Collection
Dr. Juan Camilo Calderón
Medical Doctor
All protocols validated by Juan Camilo Calderón, MD — XTETIC Medical Director. A physician trained in Dermatology and aesthetic medicine immunology. He is also a professor, scientific consultant, international speaker, and dermatology publication reviewer.
